DSCR9 and familial pancreatic carcinoma: In contrast to DSCR9 overexpression, miR-21-5p overexpression enhanced the aggressiveness of pancreatic cancer cells by promoting the proliferation and invasive ability of cancer cells and attenuating gemcitabine-stimulated apoptosis.